These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 20192940)

  • 1. Association of the interleukin-23 receptor gene variant rs11209026 with Crohn's disease in German children.
    Lacher M; Schroepf S; Helmbrecht J; Von Schweinitz D; Ballauff A; Koch I; Lohse P; Osterrieder S; Kappler R; Koletzko S
    Acta Paediatr; 2010 May; 99(5):727-733. PubMed ID: 20192940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATG16L1 and IL23R are associated with inflammatory bowel diseases but not with celiac disease in the Netherlands.
    Weersma RK; Zhernakova A; Nolte IM; Lefebvre C; Rioux JD; Mulder F; van Dullemen HM; Kleibeuker JH; Wijmenga C; Dijkstra G
    Am J Gastroenterol; 2008 Mar; 103(3):621-7. PubMed ID: 18047540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants.
    Glas J; Seiderer J; Wetzke M; Konrad A; Török HP; Schmechel S; Tonenchi L; Grassl C; Dambacher J; Pfennig S; Maier K; Griga T; Klein W; Epplen JT; Schiemann U; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Müller-Myhsok B; Folwaczny M; Mussack T; Brand S
    PLoS One; 2007 Sep; 2(9):e819. PubMed ID: 17786191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis.
    Büning C; Schmidt HH; Molnar T; De Jong DJ; Fiedler T; Bühner S; Sturm A; Baumgart DC; Nagy F; Lonovics J; Drenth JP; Landt O; Nickel R; Büttner J; Lochs H; Witt H
    Aliment Pharmacol Ther; 2007 Oct; 26(7):1025-33. PubMed ID: 17877509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel disease.
    Roberts RL; Gearry RB; Hollis-Moffatt JE; Miller AL; Reid J; Abkevich V; Timms KM; Gutin A; Lanchbury JS; Merriman TR; Barclay ML; Kennedy MA
    Am J Gastroenterol; 2007 Dec; 102(12):2754-61. PubMed ID: 17894849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic association between IL23R rs11209026 and rs10889677 polymorphisms and risk of Crohn's disease and ulcerative colitis: evidence from 41 studies.
    Zhu Y; Jiang H; Chen Z; Lu B; Li J; Shen X
    Inflamm Res; 2020 Jan; 69(1):87-103. PubMed ID: 31728561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
    Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
    Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of IL23R, TNFRSF1A, and HLA-DRB1*0103 allele variants with inflammatory bowel disease phenotypes in the Finnish population.
    Lappalainen M; Halme L; Turunen U; Saavalainen P; Einarsdottir E; Färkkilä M; Kontula K; Paavola-Sakki P
    Inflamm Bowel Dis; 2008 Aug; 14(8):1118-24. PubMed ID: 18338763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL23R and IL12B polymorphisms in Spanish IBD patients: no evidence of interaction.
    Márquez A; Mendoza JL; Taxonera C; Díaz-Rubio M; De La Concha EG; Urcelay E; Martínez A
    Inflamm Bowel Dis; 2008 Sep; 14(9):1192-6. PubMed ID: 18383521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replication of interleukin 23 receptor and autophagy-related 16-like 1 association in adult- and pediatric-onset inflammatory bowel disease in Italy.
    Latiano A; Palmieri O; Valvano MR; D'Incà R; Cucchiara S; Riegler G; Staiano AM; Ardizzone S; Accomando S; de Angelis GL; Corritore G; Bossa F; Annese V
    World J Gastroenterol; 2008 Aug; 14(29):4643-51. PubMed ID: 18698678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NOD2, IL23R and ATG16L1 polymorphisms in Lithuanian patients with inflammatory bowel disease.
    Sventoraityte J; Zvirbliene A; Franke A; Kwiatkowski R; Kiudelis G; Kupcinskas L; Schreiber S
    World J Gastroenterol; 2010 Jan; 16(3):359-64. PubMed ID: 20082483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotype.
    Cummings JR; Ahmad T; Geremia A; Beckly J; Cooney R; Hancock L; Pathan S; Guo C; Cardon LR; Jewell DP
    Inflamm Bowel Dis; 2007 Sep; 13(9):1063-8. PubMed ID: 17508420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of IL23R, JAK2, and STAT3 gene polymorphisms and gene-gene interactions in Crohn's disease and ulcerative colitis in a Turkish population.
    Can G; Tezel A; Gürkan H; Tozkır H; Ünsal G; Soylu AR; Ümit HC
    Turk J Gastroenterol; 2016 Nov; 27(6):525-536. PubMed ID: 27852544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease.
    Tremelling M; Cummings F; Fisher SA; Mansfield J; Gwilliam R; Keniry A; Nimmo ER; Drummond H; Onnie CM; Prescott NJ; Sanderson J; Bredin F; Berzuini C; Forbes A; Lewis CM; Cardon L; Deloukas P; Jewell D; Mathew CG; Parkes M; Satsangi J
    Gastroenterology; 2007 May; 132(5):1657-64. PubMed ID: 17484863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATG16L1 and IL23 receptor (IL23R) genes are associated with disease susceptibility in Hungarian CD patients.
    Lakatos PL; Szamosi T; Szilvasi A; Molnar E; Lakatos L; Kovacs A; Molnar T; Altorjay I; Papp M; Tulassay Z; Miheller P; Papp J; Tordai A; Andrikovics H;
    Dig Liver Dis; 2008 Nov; 40(11):867-73. PubMed ID: 18499543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of variants of the interleukin-23 receptor gene with susceptibility to pediatric Crohn's disease.
    Baldassano RN; Bradfield JP; Monos DS; Kim CE; Glessner JT; Casalunovo T; Frackelton EC; Otieno FG; Kanterakis S; Shaner JL; Smith RM; Eckert AW; Robinson LJ; Onyiah CC; Abrams DJ; Chiavacci RM; Skraban R; Devoto M; Grant SF; Hakonarson H
    Clin Gastroenterol Hepatol; 2007 Aug; 5(8):972-6. PubMed ID: 17618837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of association of interleukin-23 receptor gene polymorphisms with Egyptian rheumatoid arthritis patients.
    Hamdy G; Darweesh H; Khattab EA; Fawzy S; Fawzy E; Sheta M
    Hum Immunol; 2015 Jun; 76(6):417-20. PubMed ID: 25858864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common variants in NOD2 and IL23R are not associated with inflammatory bowel disease in Indians.
    Mahurkar S; Banerjee R; Rani VS; Thakur N; Rao GV; Reddy DN; Chandak GR
    J Gastroenterol Hepatol; 2011 Apr; 26(4):694-9. PubMed ID: 21155887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication of an association between IL23R gene polymorphism with inflammatory bowel disease.
    Oliver J; Rueda B; López-Nevot MA; Gómez-García M; Martín J
    Clin Gastroenterol Hepatol; 2007 Aug; 5(8):977-81, 981.e1-2. PubMed ID: 17678845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.